ACTH	adrenocorticotropic hormone
ALS	amyotrophic lateral sclerosis
ARAS	ascending reticular activation system
ARC	arcuate nucleus
BAT	brown adipose tissue
BBB	blood–brain barrier
BNST	bed nucleus of stria terminalis
CeA	central amygdala
CCK	cholecystokinin
CNS	central nervous system
CSF	cerebrospinal fluid
CRH	corticotrope-releasing hormone
DMH	dorsomedial hypothalamus
DR	dorsal raphe
FDA	the Food and Drug Administration
GABA	$\gamma$-amino-butyric-acid
GAS	general adaptation syndrome
GPCRs	G-protein-coupled receptors
HPA	hypothalamic–pituitary–adrenal cortex
HPG	hypothalamic–pituitary–gonadal axis
IC	insular cortex
LA	lateral amygdala
LC	locus coeruleus
LDT	lateral dorsal tegmental nuclei
LHA	lateral hypothalamic area
MCH	melanin-concentrating hormone
MDD	major depressive disorder
MnPO	median preoptic nucleus
MPO	medial preoptic nucleus
MS	multiple sclerosis
MT	mesopontine tegmentum
MTL	medial temporal lobe
NAc	nucleus accumbens
NIBS	non-invasive brain stimulation techniques
NK	neurokinin
NM	neuromedin
NMS	neuromedin S
NPY	neuropeptide Y
NST	nucleus of the solitary tract
NT	neurotensin
OVLT	organum vasculosum laminae terminalis
OX1R	orexin-1 receptor
OX2R	orexin-2 receptor
OXR	orexin receptor
PAG	periaqueductal gray
PCOS	polycystic ovary syndrome
PFA	perifornical area
PFC	prefrontal cortex
POMC	pro-opiomelanocortin
PON	preoptic nucleus
PPT	pedunculopontine tegmental nucleus
PVN	paraventricular nuclei
RVLM	rostral ventrolateral medulla
RVMM	rostral ventromedial medulla
SA	sympathoadrenal
SCN	suprachiasmatic nucleus
SON	supraoptic nucleus
tDCS	transcranial direct current stimulation
TMs	transcranial magnetic stimulation
TMN	tuberomammillary nucleus
VMH	ventromedial hypothalamus
VTA	ventral tegmental area
VLPO	ventrolateral preoptic nucleus